Vanguard European Stock Index Fund Investor (VEURX)
40.20
-0.72
(-1.76%)
USD |
Jun 20 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.24% | 32.38B | 3.01% | 3.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 3.257B | 14.20% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe. The Fund employs an indexing investment approach by investing all of its assets in the common stocks included in the FTSE Developed Europe All Cap Index. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Europe |
| Peer Group | European Region Funds |
| Global Macro | Equity Europe |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | European Region Funds |
| Fund Owner Firm Name | Vanguard |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
4
-322.96M
Peer Group Low
964.31M
Peer Group High
1 Year
% Rank:
4
3.257B
-4.023B
Peer Group Low
3.257B
Peer Group High
3 Months
% Rank:
4
-944.05M
Peer Group Low
4.326B
Peer Group High
3 Years
% Rank:
4
-6.325B
Peer Group Low
2.446B
Peer Group High
6 Months
% Rank:
4
-2.282B
Peer Group Low
4.968B
Peer Group High
5 Years
% Rank:
4
-1.347B
Peer Group Low
7.509B
Peer Group High
YTD
% Rank:
4
-407.29M
Peer Group Low
5.436B
Peer Group High
10 Years
% Rank:
4
-18.95B
Peer Group Low
5.140B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of June 23, 2025.
Asset Allocation
As of April 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.11% |
| Stock | 98.18% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.38% |
| Other | 1.32% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| SAP SE | 2.39% | 285.62 | -2.15% |
| ASML Holding NV | 2.06% | 750.22 | -0.72% |
| Nestle SA | 1.98% | 99.23 | -2.29% |
|
Vanguard Market Liquidity Fund
|
1.74% | -- | -- |
| Novartis AG | 1.64% | 116.13 | 0.00% |
| Novo Nordisk AS | 1.64% | 73.79 | -0.71% |
| Roche Holding AG | 1.60% | 310.73 | -2.44% |
| AstraZeneca PLC | 1.58% | 139.69 | -2.72% |
| HSBC Holdings PLC | 1.52% | 11.58 | -2.44% |
| Shell PLC | 1.45% | 36.45 | 0.72% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.22% |
| Administration Fee | 25.00K% |
| Maximum Front Load | 0.00% |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors | No |
| Minimum Initial Investment | 3000.00 None |
| Minimum Subsequent Investment | 1.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe. The Fund employs an indexing investment approach by investing all of its assets in the common stocks included in the FTSE Developed Europe All Cap Index. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Europe |
| Peer Group | European Region Funds |
| Global Macro | Equity Europe |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | European Region Funds |
| Fund Owner Firm Name | Vanguard |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (6-20-25) | 2.91% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 23.35 |
| Weighted Average Price to Sales Ratio | 3.631 |
| Weighted Average Price to Book Ratio | 4.347 |
| Weighted Median ROE | 18.09% |
| Weighted Median ROA | 6.16% |
| ROI (TTM) | 11.51% |
| Return on Investment (TTM) | 11.51% |
| Earning Yield | 0.0601 |
| LT Debt / Shareholders Equity | 0.8150 |
As of April 30, 2025
Growth Metrics
| EPS Growth (1Y) | 12.77% |
| EPS Growth (3Y) | 10.66% |
| EPS Growth (5Y) | 10.29% |
| Sales Growth (1Y) | 5.19% |
| Sales Growth (3Y) | 8.12% |
| Sales Growth (5Y) | 6.32% |
| Sales per Share Growth (1Y) | 8.22% |
| Sales per Share Growth (3Y) | 8.87% |
| Operating Cash Flow - Growth Ratge (3Y) | 7.74% |
As of April 30, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:VEURX", "name") |
| Broad Asset Class: =YCI("M:VEURX", "broad_asset_class") |
| Broad Category: =YCI("M:VEURX", "broad_category_group") |
| Prospectus Objective: =YCI("M:VEURX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |